such as the entorhinal cortex and hippocampus, additionally implicating pathways 48 associated with disease progression. We believe this resource and the analyses 49 Introduction 70 Microglia are the most abundant myeloid cell type in the central nervous system 71 (CNS), accounting for approximately 5-20% of the brain parenchyma depending on 72 region (Lawson, Perry, Dri, & Gordon, 1990; Mittelbronn, Dietz, Schluesener, & 73 Meyermann, 2001) . These cells are phenotypically plastic and exhibit a wide 74 spectrum of activity influenced by local and systemic factors (Cunningham, 2013; 75 Perry & Holmes, 2014) . Through development into adulthood, microglia influence the 76 proliferation and differentiation of surrounding cells while regulating processes such 77 as myelination, synaptic organization and synaptic signaling (Colonna & Butovsky, 78 2017; Hoshiko, Arnoux, Avignone, Yamamoto, & Audinat, 2012; Paolicelli et al., 79 2011; Prinz & Priller, 2014) . As the primary immune sentinels of the CNS, microglia 80 migrate towards lesions and sites of infection, where they attain an activated state 81 that reflects their inflammatory environment (Leong & Ling, 1992) . In these states, 82 they can support tissue remodeling and phagocytose cellular debris, toxic protein 83 aggregates and microbes (Colonna & Butovsky, 2017; Li & Barres, 2017) . During 84 neuroinflammation these cells coordinate an immune response by releasing 85 cytokines, chemoattractants and presenting antigens, thereby communicating with 86 other immune cells locally and recruited from the circulation (Hanisch & Kettenmann, 87 2007; Hickey & Kimura, 1988; Scholz & Woolf, 2007) . 88
In common with mononuclear phagocyte populations throughout the body, recent 89 studies have begun to reveal the diversity of microglial phenotypes in health, aging 90 and disease states, as well as their unique molecular identity in relation to other CNS 91 resident cells and non-parenchymal macrophages (Durafourt et al., 2012; Hanisch, 92 2013; Li & Barres, 2017; McCarthy; Salter & Stevens, 2017) . The application of 93 transcriptomic methods has been integral to these advances by enabling an 94 unbiased and panoramic perspective of the functional profile of microglia. In addition 95 to an improved understanding of the variety of context-dependent microglial 96 phenotypes, other key benefits have arisen from these studies, notably the 97 development of new tools to label, isolate and manipulate microglia (Bennett et al., 98 2016; Butovsky et al., 2014; Hickman et al., 2013; Satoh et al., 2016) . Although most 99 studies have been conducted in mice, a considerable body of data is now emerging 100 from human post-mortem and biopsy tissue (Darmanis et al., 2015; Galatro et al., 101 ≥ 0.7 and thereby graphs 187 included only correlations that were highly unlikely to occur by chance ( Figure S1 ). 188
For each dataset, the threshold for correlations was further adjusted to achieve a 189 single microglial cluster containing the three canonical marker genes for microglia, 190 CX3CR1, AIF1 and CSF1R (Elmore et al., 2014; Mittelbronn et al., 2001) . The final 191 microglial gene signature was defined by genes present in at least three of the nine 192 dataset derived microglial signatures (Table S2 and S3). 193 Validation of the core human microglial signature 194
Various lines of evidence were investigated to validate the conserved nature of the 195 derived human microglial signature. Firstly, the average expression of signature 196 genes was compared between myeloid and other cell types from an atlas of primary 197 human cells (Mabbott et al., 2013) , using the Mann-Whitney U test. Similarly, the 198 average expression of signature genes in the GTEx RNA-Seq data and donor one of 199 confidence microglia gene signature was defined by 249 genes, which were present 283 in three or more dataset-derived clusters, so as to avoid biases towards individual 284 datasets. However, it should be noted that the 395 genes observed in at least two 285 dataset-derived microglial clusters also showed a strong enrichment for genes with a 286 known immunobiological function (Table S3 ). 287
Validation and description of the core human microglial signature 288 To validate the microglial signature genes, various lines of evidence were examined. 289
First, a comparison of the average expression of core signature genes across cell 290 types revealed a significantly higher (P < 0.001) expression in myeloid cells relative 291 to other immune (most of which are scarce within non-neuropathologic brain tissue) 292 and CNS cell types ( Figure 2B ) (Ginhoux et al., 2010) . Second, the average 293 expression of core genes across brain regions in the GTEx and ABA datasets 294 correlated with regional microglial densities as measured in the mouse (Figure 295 2C) (Lawson et al., 1990) . Third, where data was available, the IHC staining of 296 proteins encoded by signature genes was examined in the CNS. This confirmed the 297 microglial expression of known markers e.g. AIF1, as well as less characterized 298 proteins in the core set, e.g. APBB1IP, ABI3, FCER1G and ARHGDIB, which 299 specifically stained for microglia across the four regions analyzed by the HPA 300 resource ( Figure 3A ) (Nilsson et al., 2005) . Finally, GO enrichment analysis was 301 performed and complemented by manual annotation of the core human microglial 302 gene signature. Literature mining showed most genes in the list to have some 303 association with microglial/macrophage biology and overall there was a significant 304 enrichment in genes known to be associated with microglial processes (Table S3, 4) . 305
These include TLR signaling (TLR1, TLR2), complement pathway (C3AR1, C1QA 306 and C2), TYROBP signaling (TREM2, TYROBP), and cytoskeletal organization 307 (AIF1, CAPG and WAS) ( Figure 3C ) (Hong et al., 2016; Marinelli et al., 2015; Yeh, 308 Hansen, & Sheng, 2017) . Genes recently identified as highly enriched in human or 309 mouse microglia, relative to other macrophages and CNS cells, were also present in 310 the signature (e.g. GPR34, P2RY12, P2RY13, TMEM119) (Butovsky et al., 2014) . 311
The core signature was then compared to the published microglial signatures from 312 both human and mouse ( Figure 3B ). The majority of genes (248 genes) overlapped 313 with signatures from earlier works, with HLA-DRB3 being unique to this study. Over 314 half of the core signature genes included those overlapping between published 315 human and mouse signatures, while the remaining genes were specific to previous 316 signatures in human (113 and 134 respectively). A majority of the core signature 317 genes (64%, 142 genes) were identified in two or more human studies, whilst 99 318 genes overlapped solely with the Galatro et al. signature. To further validate the 319 specificity of the current microglial signature, the coexpression of these genes was 320 compared with that of the Galatro et al. signature (1,236 genes) , which included the 321 majority of genes in other signatures. On constructing a GCN from the GTEx Seq dataset, genes of the current signature were strongly coexpressed with one 323 another within the network graph ( Figure 4A ). Many Galatro et al. signature genes 324 were similarly coexpressed, however, many others were scattered across the 325 network, indicative of an overall poor correlation between them in comparison to the 326 current signature ( Figure 4B ). Cluster analysis showed a contrast in the expression 327 profiles of clusters enriched in Galatro et al. signature genes relative to the microglial 328 cluster as defined by marker genes (cluster 6, Figure 4C , D, and E). The expression 329 pattern of these clusters deviated from the microglial cluster 6 and presented 330 significant (FDR < 0.001) region-specific expression (Table S5 ). For instance cluster 331 1 containing 94 genes from the Galatro et al. signature were highly expressed in the 332 cerebellum, a brain region having a low number of microglia. On comparing these 333 genes with a recently published list of cerebellum-specific mouse microglial genes 334 (Grabert et al., 2016) , only three genes coincided and analysis of HPA IHC data 335 suggested that whilst some were specifically expressed in microglia in other regions, 336 they were not microglial specific in the cerebellum ( Figure S2 ). 337
Microglia in Alzheimer's disease 338
We next used the 249 gene signature to assess the human microglial profile in aging 339 and Alzheimer's through analysis of a transcriptomics dataset derived from cortical 340 and hippocampal regions of Alzheimer's patients and non-neuropathic controls 341 (Berchtold et al., 2013) (Table S1 ). As a preliminary analysis, the average expression 342 of signature genes was used as a proxy measure of microglial number and 343 calculated for all 20 yr age groups across regions ( Figure 5A ). Apart from the 344 entorhinal cortex, a significant increase in expression of core genes was observed 345 with aging. For example, in the hippocampus, a 1.6 fold change (FC) in expression 346 (FDR < 0.01) was observed between the oldest and youngest control age groups. 347
The lack of significance for the entorhinal cortex is likely attributed to the significant 348 variation between samples across the different age groups. On comparing the 349 average expression of core genes in Alzheimer's with age-matched controls, the 350 superior frontal gyrus showed a significant increase in Alzheimer's samples (FC = 351 1.2, FDR < 0.05), a region known to be significantly affected in both aging and 352
Alzheimer's, based on neuronal connectivity studies (Bakkour, Morris, Wolk, & 353 Dickerson, 2013; Stam, 2014) . Although non-significant, other regions also showed a 354 consistent increase in expression of the signature genes relative to age-matched 355
controls. 356
Based on the hypothesis that microglia in Alzheimer's not only increase in number 357 but are also phenotypically altered by the presence of misfolded beta-amyloid protein 358 and other potential biochemical stressors, we sought to identify other genes which 359 were specifically coexpressed with the core signature genes across in brain samples 360 from Alzheimer's patients (Manocha et al., 2016) . A GCN was generated using only 361 those samples derived from Alzheimer's patients (r ≥ 0.7), and two clusters were 362 found enriched in core microglial genes based on a Fisher's exact test (adj. P < 363 0.01). The 165 non-core genes were also present in these clusters, i.e. coexpressed 364 with the core genes and used for downstream analyses ( Figure 5B , Table S6 ). 365 Enrichment analyses of these MAGs conducted using ToppGene (Chen et al., 2009) 366 revealed GO terms associated with cell activation, wound healing, angiogenesis, 367 apoptosis and immune defense response (Table S7 ). These analyses were 368 complemented by an enrichment in the MAGs for pathways linked to platelet 369 activation, NFKB signaling, TGFB-SMAD signaling and VLDL metabolism. 370
Additionally, an enrichment of the ETS2 binding site was observed in these genes, a 371 transcription factor implicated in Alzheimer's and a known transactivator of the APP 372 promoter (Wolvetang et al., 2003) . 373
In order to identify quantitatively, genes specifically associated with microglia in 374
Alzheimer's but not aging, a differential expression analysis was conducted based on 375 the MAGs and core genes, to compare the response of microglia in aging and 376
Alzheimer's. Thus, the expression fold change between the old (≥60 yr) and young, 377 was compared with that of Alzheimer's and age-matched controls ( Figure 5C , Table  378 S6). Reinforcing our preliminary analysis in estimating microglial numbers in 379
Alzheimer's versus age-matched controls, the majority of differentially expressed 380 genes (FDR < 0.05) were restricted to the superior frontal gyrus. Interestingly, the 381 trends in expression for each region (represented by the regression line) matched 382 the degree to which each region undergoes neurodegeneration in Alzheimer's, e.g. 383 the post-central gyrus, which is comparatively unaffected in Alzheimer's relative to 384 other regions of the brain (Thompson et al., 2003) , showed the least upward trend 385 (intercept = -0.01, slope = 0.23). In contrast gene expression in the entorhinal cortex 386 and hippocampus, regions considered vulnerable to Alzheimer's showed an upward 387 trend, highlighting the significance of these genes in Alzheimer's and not only aging. 388
Although the genes differentially expressed across regions were not all the same, 389 certain genes such as SAMSN1 (superior frontal gyrus: FC = 1.48, FDR < 0.003) 390 and CX3CR1 (superior frontal gyrus: FC = 0.88, FDR < 0.707) had a consistent 391 expression pattern across regions when comparing the expression fold change in 392
Alzheimer's and aging. To better characterize the microglial response in Alzheimer's, 393
we focused on the superior frontal gyrus, having the most number of differentially 394 expressed genes and a significantly affected region in Alzheimer's. In identifying 395 genes likely representing changes in activation state rather than cell number, we 396 considered the 52 genes differentially expressed only in Alzheimer's versus age-397 matched controls. Here, genes also differentially expressed in aged versus young 398 were excluded as they are known to be influenced by microglia abundance. 399 Enrichment analysis of these genes highlighted processes related to cell activation 400 (PYCARD and PIK3CG), wound healing (A2M and SERPING1), innate immune 401 response (TLR5 and ITGAM), and pathways associated with phagocytosis, TLR 402 cascade, and cell activation linked with neuronal survival (Table S8 ). Moreover, 403 several members of TYROBP signaling pathway were differentially expressed 404 (SAMSN1, SIRPβ2, CD37, IL10RA, PIP3CG and BIN2), a pathway dysregulated in 405 microglia during Alzheimer's (Keren-Shaul et al.; Ma, Jiang, Tan, & Yu, 2015; B. 406 Zhang et al., 2013) . Of the differentially expressed genes, eleven were MAGs 407 including LYZ, RPS6KA1 and SLA, with known associations to Alzheimer's (Ellison, 408 Bradley-Whitman, & Lovell, 2017; Hu, Xin, Hu, Zhang, & Wang, 2017; Tuppo & 409 Arias, 2005) . Interestingly, certain classical microglial marker genes were 410 differentially upregulated in Alzheimer's e.g. ITGAM and PTPRC, while others 411 showed a downward trend, including CX3CR1 and P2RY12; the latter consistent 412 with a loss of homeostatic microglial genes observed in Alzheimer's mouse models 413 (Keren-Shaul et al.) . Alternatively, whilst tissue gene expression can be influenced 414 by cell activation and cell numbers, certain genes found differentially upregulated in 415 both Alzheimer's and aging, such as TSPO, MS4A6A and MHC class 2 genes, are 416 known contributors of microglial activation based on previous studies (Bergen, 417 Kaing, Jacoline, Gorgels, & Janssen, 2015; Hamelin et al., 2016; Hu et al., 2017) . 418
Overall, these observations demonstrate the value of the refined microglial signature 419 we have derived in deducing changes in microglial profile (numbers and functional 420 status) in Alzheimer's and are consistent with the region-specific vulnerability and 421 progression of Alzheimer's pathology. 422
Discussion

423
Recent transcriptomic studies, majority of which have been conducted in mice, have 424 greatly advanced our knowledge of the functional profile of microglia (Butovsky et al., 425 2014; Darmanis et al., 2015; Galatro et al., 2017; Hickman et al., 2013; Zeisel et al., 426 2015 ), their regional heterogeneity in the CNS (Grabert et al., 2016) , and altered 427 profile associated with neurodegeneration (Keren-Shaul et al.; Miller et al., 2010; 428 Vincenti et al., 2016) . Additionally, key differences between mouse and human 429 microglia have been suggested (Galatro et al., 2017; Olah et al., 2018) , emphasizing 430 the importance of better characterizing the functional profile of human microglia in 431 health and disease. Our initial investigations demonstrated that published microglia 432 gene signatures vary considerably in their size and composition relative to one 433 another. Contributors of the observed discrepancy are likely the differing 434 experimental objectives, p-value thresholds or fold-change enrichment in defining 435 signature genes, donor variability, differing analysis platforms/methods, regions 436 examined and cell isolation methodologies (Okaty, Sugino, & Nelson, 2011) . Indeed, 437 there appears to be little consensus amongst current studies over the functional 438 profile of microglia beyond a few well-known markers, e.g. AIF1, CSF1R and 439 CX3CR1 (Elmore et al., 2014; Mittelbronn et al., 2001) . 440
To identify a conserved human microglial signature, we used an unbiased correlation 441 network analysis, harnessing the power of cell and tissue transcriptomics data 442 including two large studies; namely the GTEx and ABA datasets. Together they 443 provide the largest publicly available transcriptomic datasets covering a 444 comprehensive range of brain regions, collected from numerous donors (Hawrylycz 445 et al., 2012; Lonsdale et al., 2013) . GCNs were constructed to identify groups of 446 genes with similar expression profiles, corresponding to cells or pathways, as has 447 been shown possible using this approach (Tom C. Freeman et al., 2012; Mabbott et 448 al., 2013; B. B. Shih et al., 2017) . From each dataset, a microglia cluster was 449 identified, based on the presence of canonical marker genes for these cells. The 450 consensus from these dataset derived signatures, provided 249 genes 451 representative of human microglia across datasets. To our knowledge, this is the first 452 study to deconvolute a microglia signature from the current GTEx and ABA tissue 453 data. The derived signature included all known markers of microglia, including 454 TMEM119, P2RY12, and CD68 (Bennett et al., 2016; Perego, Fumagalli, & De 455 Simoni, 2011; Wes, Holtman, Boddeke, Möller, & Eggen, 2016) and many other 456 genes known to be associated with microglial/macrophage biology. This includes 457 representatives of the TLR, complement, and MHC class 2 antigen-presenting 458 immune pathways. 459
Validation of the signature, included an examination of HPA immunostaining of 460 proteins encoded by the signature genes, demonstrating that they were significantly 461 expressed in myeloid cell types relative to other neuronal and immune cells, and 462 comparison with published microglial signatures. This final step revealed approximately half of the core genes as conserved between species, reaffirming the 464 widely accepted idea that many constitutively expressed microglial genes are 465 conserved between mouse and human. Although their response to processes like 466 aging may diverge (Bennett et al., 2016; Galatro et al., 2017) . To examine the 467 specificity of the core signature, a comparison was made with the Galatro et al. 468 (Galatro et al., 2017) signature, derived by comparing the fold expression of 469 microglia isolated from the parietal cortex of post-mortems, relative to whole tissue. 470
The signature provides an insight into human microglial functionality under 471 homeostasis and has a high degree of overlap with current signatures, although 472 being significantly larger. Using the GTEx brain atlas data the coexpression and 473 regional expression of both signatures were investigated. Many of the Galatro el al. 474 signature genes showed poor coexpression while displaying a range of region-475 specific expression patterns, deviating from those of canonical marker genes like 476 CSF1R, AIF1 and CX3CR1. Whilst these genes are likely to be expressed in 477 microglia (as originally identified), these results underscore the regional 478 heterogeneity of microglia, suggesting that certain genes specific to cortical microglia 479 may not be solely expressed by microglia in other regions. Indeed, certain of the 480 Galatro signature genes, also common to other studies, expressed highly in the 481 cerebellum presenting a multi-cell type expression in this region based on IHC data 482 from the HPA, making them poor markers of microglia. Additionally, these genes did 483 not agree with cerebellum-specific genes identified in mouse (Grabert et al., 2016). 484 In contrast, our core signature exhibited a well-defined and condensed coexpression 485 pattern corresponding to the known regional CNS variation in microglial abundance. 486 Therefore, while isolated cells have provided fundamental insight into microglial 487 identity, coexpression analysis of the employed datasets aids in defining the 488 microglial specific profile in the CNS. 489
Evidence for the central role microglia play in the pathogenesis of neurodegenerative 490 disease continues to grow, however, the cellular and molecular changes that occur 491 in human brain pathologies are poorly understood. Furthermore, using the core 492 signature we conducted various analysis, to discern the influence of cell number and 493 activation state in both healthy aging and Alzheimer's, across a number of brain 494 regions using the dataset generated by Berchtold et al. (Berchtold et al., 2013). 495 Given that the majority of microglial genes maintain their expression with age (Galatro et al., 2017; Jyothi et al., 2015; Poliani et al., 2015) , we made the 497 assumption that the average expression of the signature genes, can be used as a 498 proxy for microglia number through aging. Supporting this, the increased average 499 expression of signature genes with age was substantiated by studies directly 500 measuring cell numbers with age (Damani et al., 2011; Peters, Josephson, & 501 Vincent, 1991; Tremblay, Zettel, Ison, Allen, & Majewska, 2012) . The largest 502 changes were observed in the hippocampus, a region particularly vulnerable to aging 503 and where greater microglial activation and neuronal loss have been observed with 504 age relative to other cortical regions (Bartsch & Wulff, 2015; Galatro et al., 2017; 505 Kumar et al., 2012; Raz et al., 2005) . Therefore, these analyses support the idea that 506 microglial numbers change in a region-dependent manner and that these changes 507 correlate with age-associated regional atrophy and inflammation. When comparing 508
Alzheimer's to age-matched controls, a similar trend towards increased expression 509 levels of signature genes was also observed. However, a significant increase was 510 only observed in the superior frontal gyrus, a region known to be highly susceptible 511 to the effects of both aging and Alzheimer's, based on neuronal connectivity studies 512 (Bakkour et al., 2013; Stam, 2014) . Interestingly, the entorhinal cortex and 513 hippocampus, whose atrophy characterize Alzheimer's pathology, showed the 514 greatest differences between Alzheimer's and controls, although lacking statistical 515 significance, likely due to the relatively small number of samples and large variability 516 between them (Khan et al., 2014; Velayudhan et al., 2013) . In contrast, the post-517 central gyrus, a region shown to maintain its grey matter content and functional 518 connectivity with other regions in late-onset Alzheimer's, showed little change in 519
Alzheimer's versus controls (Adriaanse et al., 2014; Thompson et al., 2003) . 520
Strikingly, these findings are consistent with regional Alzheimer's progression based 521 on tau burden, neuroinflammation and neuronal loss, which are prominent in the 522 entorhinal cortex and hippocampus (Cope et al., 2017; Freer et al., 2016; Kreisl et 523 al., 2016) . Overall, these data demonstrate the utility of the signature in assessing 524 quantitative differences in microglial numbers from tissue-level expression datasets. 525
To gain insight into molecular pathways specifically affected in Alzheimer's, 526
qualitative changes in the profile of microglia were examined. Coexpression analysis 527 identified a set of 165 MAGs correlating with the core gene signature in samples 528 isolated from Alzheimer's patients. The MAG list was enriched in various pathways 529 associated with innate immune signaling, consistent with the inflammatory 530 environment within Alzheimer's brain tissue and the reactivity of microglia within this 531 environment, namely TSPO (Kumar et al., 2012) . It was particularly interesting to 532 note that genes involved in lipid regulation and wound healing, associated with 533
Alzheimer's, were over-represented in the MAGs set (Cervantes et al., 2011; Lorenzl 534 et al., 2003; Petit-Turcotte et al., 2001; Y.-H. Shih et al., 2014) . Members of the 535 APOC gene family and ECHDC3 are known to regulate levels of certain lipids, linked 536 with Alzheimer's progression (Adunsky et al., 2002; Desikan et al., 2015; Lane & 537 Farlow, 2005) . Additionally, these factors are part of the wound healing cascade, 538
including proteins such as TIMP1 and PROS1, which are key in regulating tissue 539 integrity and plasticity, altogether pointing towards the vulnerable blood-brain barrier 540 in Alzheimer's (Bennett et al., 2016; Duits et al., 2015) . These results provide some 541 insight and support for the complexity of microglia involvement in Alzheimer's 542 through not only inflammatory mechanisms but also through upregulation of 543 metabolic and tissue homeostasis/repair functions (Vincenti et al., 2016) . 544
Investigating quantitative alterations of microglial differentiation in Alzheimer's, we 545 focussed on genes differentially expressed in Alzheimer's compared to age-matched 546 controls. Although for all regions, the majority of genes presented an upward trend of 547 expression, most lacked significance, excluding those of the superior frontal gyrus 548 which we further investigated. Genes relating to TYROBP signaling, which is 549 implicated in Alzheimer's and together regulates phagocytosis, cell proliferation, 550 activation and survival were significantly upregulated (Keren-Shaul et al.; Landreth & 551 Reed-Geaghan, 2009; Ma et al., 2015) . Substantiating these findings TYROBP 552 knockout mice models have proven to suppress inflammation in neurodegenerative 553 models including Alzheimer's, thereby minimizing neuronal dystrophy, implicating a 554 failure in the resolution of inflammation in Alzheimer's (Bakker et al., 2000; Haure-555 Mirande et al., 2017) . Interestingly mutations and expression of downstream 556 members are also linked with Alzheimer's including CD33, TREM2 and CR3 557 (Hamerman, Tchao, Lowell, & Lanier, 2005; Takahashi, Rochford, & Neumann, 558 2005) . 559
In summary, we have employed a coexpression analysis approach to derive a core 560 human microglial signature under non-neuropathologic conditions that is robust to 561 potential artifact generated by technical and biological variation (e.g. donors and 562 CNS regions) that can influence other approaches in signature derivation. 563 Furthermore, we present the utility of this signature, demonstrating its sensitivity to 564 detect region-specific changes in microglial alterations in aging and Alzheimer's 565 disease, while appreciating the influence of cell numbers and activation in tissue 566 transcriptomics data. We found that these responses were aligned with the known 567 neuropathological trajectory of Alzheimer's. We propose the conserved signature 568 described here as a specific and robust resource of gene markers that reflect the 569 core functional profile of these cells and aid future studies of microglial biology in the 570 
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Alzheimer's and not in aging. 870 871 dataset (upper panel) a microglial-specific cluster was identified using coexpression 880 network analysis (blue sectors). In comparing these gene clusters, 395 overlapped 881 across more than one dataset (green sector). From this set of overlapping genes, 882 green lines connect a specific gene to all datasets in which it was identified. Of the 883 overlapping genes, those co-occurring in three or more datasets were taken to 884 represent the core microglial signature (red sector). (B) Average expression of core 885 signature genes in various neuronal and immune cell types selected from an 886 expression atlas of primary cells (Mabbott et al., 2013) . (C) Comparison of the 887 average expression across tissue transcriptomics data and microglial cell numbers in 888 mouse, for regions common to the respective studies (Lawson et al., 1990) . 889
Figure Legends
Abbreviations -AU: Arbitrary units; sig: Signature; ABA: Allen Brain Atlas; Ctx F: 890 Frontal cortex; Ctx: Cortex; SN: Substantia Nigra; Cbm: Cerebellum. *** significant at 891 P < 0.001. 892 taken from the HPA resource (Nilsson et al., 2005) , and show that in the cerebellum 934 their expression is not restricted to microglia. 935
